chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day 1: elevated temperature, extreme fatigue, pain at injection site Day 2-10: extreme fatigue, pain in muscle under injection site Day 10-12: redness, swelling,  developed rash the size of a female palm that was hot to the touch.  Not circular but large. Painful to touch injection site / rash area. Arm hurt to lift  passed the shoulder. Extreme fatigue. Day 12: Attended walk-in clinic for assessment. Doctor reports infection in the muscle under injection site. Prescribed Cephalexin, 500 mg, 4 times daily for 7 days. Day 13: Reduction in all symptoms except arm lifting pain and extreme fatigue.
Got an unscheduled period three weeks early; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were reported as none. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 02Apr2021, a week after receiving the vaccine the patient experienced an unscheduled period three weeks early. The patient had never missed period neither was late or gotten it early. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event irregular period was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
This patient was given a monovalent pfizer covid vaccine that 9 days prior had been a standard or care.  At that time, I was unaware that I was not to administer anymore monovalent boosters as we were doing prior to 09/01/2022.  This was NOT associated with any adverse event in this patient.  At the time, we also had no supply of the new bivalent vaccine.
Rash/ red marks on his lower right back; pain in his left arm that affected his ability to lay down and sleep last night; Pain in the arm; Pain in the arm that was injected, and spread to the shoulder; weakness; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 56-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 10th October 2019).   On 28th January 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 28th January 2020, 2 hrs after receiving Shingrix, the patient experienced pain in arm, shoulder pain and weakness. On 29th January 2020, the patient experienced sleep disturbance. On 30th January 2020, the patient experienced rash. The patient was treated with hydrocortisone (Cortizone Cream). On an unknown date, the outcome of the pain in arm, shoulder pain and weakness were not recovered/not resolved and the outcome of the sleep disturbance and rash were unknown.   It was unknown if the reporter considered the pain in arm, shoulder pain, weakness, sleep disturbance and rash to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix vaccine and about 2 hours later, the patient reported pain in the arm that was injected and spread to the shoulder. The patient also experienced weakness. The patient went to urgent care and was discharged with advice to place heat on the injection site. The patient had excruciating (severe) pain in his left arm that affected his ability to lay down and sleep at night. The patient also had red marks on his lower right back also described as a rash and recommended to use Cortizone cream. The emergency room visit was required for patient. The reporter did not consent to follow up
In the evening after the vaccines, the patient's left arm became swollen up to her shoulder.   She had swelling in her tongue, multiple episodes of vomiting, and a severe headache.  By morning the swelling was starting to improve, her tongue was only tingling, the vomiting was less frequent, and her headache had improved.
COLD; SWEATING; HEADACHE; This spontaneous case was reported by a patient and describes the occurrence of NASOPHARYNGITIS (COLD), HYPERHIDROSIS (SWEATING) and HEADACHE (HEADACHE) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050C21A and 033C21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included OLANZAPINE HYDROCHLORIDE for an unknown indication.   On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jun-2021, the patient experienced NASOPHARYNGITIS (COLD) and HEADACHE (HEADACHE). 22-Jun-2021, the patient experienced HYPERHIDROSIS (SWEATING). At the time of the report, NASOPHARYNGITIS (COLD), HYPERHIDROSIS (SWEATING) and HEADACHE (HEADACHE) outcome was unknown.            No treatment drug details was reported.
weakness; Chills; headache; Sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), CHILLS (Chills), HEADACHE (headache) and VACCINATION SITE PAIN (Sore at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced ASTHENIA (weakness), CHILLS (Chills), HEADACHE (headache) and VACCINATION SITE PAIN (Sore at the injection site). At the time of the report, ASTHENIA (weakness), CHILLS (Chills), HEADACHE (headache) and VACCINATION SITE PAIN (Sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Follow-up received 25-JUN-2021 included no new information. On 12-Jul-2021: Follow-up received on 12-JUL-2021 and reporter contact details updated
Liver transplant; This case was reported by a consumer via call center representative and described the occurrence of liver transplant in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th November 2021, the patient received the 1st dose of Shingrix. On 21st November 2021, 6 days after receiving Shingrix, the patient experienced liver transplant. The patient was treated with immunosuppressants nos (Immunosuppressant Drug (Nos)). On an unknown date, the outcome of the liver transplant was unknown.   It was unknown if the reporter considered the liver transplant to be related to Shingrix.  Additional details were reported as follows: The reporter was the concerned patient. The age at vaccination was not reported. On 21st November 2021, the patient had liver transplant. The patient was on anti-rejection medications which lowered immune system protection. The patient asked if he/she need to be concerned about getting second Shingrix vaccine. Consent to follow up was requested.
Within 24 hours patient reported SOB and chest pain.   Medication Error:  patient was given Pfizer as a booster on 2/28/2021 yet Moderna was her 1st Vaccine on 1/31/2021.  No reactions day of vaccines.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Oct2021 as dose 3 (booster), single (Lot number: ew0173), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "reactive airway" (unspecified if ongoing); "IBS" (unspecified if ongoing); "sulfa" (unspecified if ongoing); "known allergies: lactose" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Codeine, reaction(s): "known allergies". The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.; Sender's Comments: Based on the information available a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events of covid-19 and drug ineffective.
Coughing; sob; fatigue; loss of appetite; weight loss; increased heart rate; abnormal thyroid and abnormal labs
Pain in armpit for one day, weakness in the whole arm for one day, nodule in muscle where shot administered.
Shortly after receiving the vaccine, patient felt faint. Pt. was placed in a chair. Patient began to sweat profusely and lost color in his face but never loss consciousness. He also claimed he was feeling nauseous. Patient received a cool rag  for his forehead and patient requested a dose of benadryl. He was given 10ml of liquid benadryl 12.5mg/5ml. Within approximately 30 minutes, pt began to feel better.
patient states that it "kick started" her period.  Patient began period earlier than normal and is now on that 28 day cycle with no further changes.
While visiting my sister-in-law with my girlfriend who had attended a wedding on 6/25-26/22, my girlfriend tested positive for Covid on 6/29/22, my sister-in-law tested positive on 6/30/22, and I tested positive on 7/1/22. Late afternoon on 6/29/22, I experienced a coughing attack. On 6/30/22, I was feeling fatigued.  I went immediately to Urgent Care on the morning of 7/1/22, was tested again, deemed positive, and received a prescription for Paxlovid. I immediately began feeling better after the initial dose of Paxlovid. On 7/5/22, I tested negative. and have been feeling well, until this morning (7/7/22). This morning, I have been feeling fatigued and have had bouts of coughing. I tested negative again today.
No additional adverse effect reported; she missed her scheduled dates for receiving her follow up shots for GARDASIL-9; This spontaneous report as received from a female patient of unknown age who was reporting on herself. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On an unknown date in June 2018, the patient was vaccinated with dose hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) intramuscularly (dose, lot # and expiration date were not reported) as a required shot.  On an unknown date in August 2018, the patient missed her scheduled dates for receiving her follow up shots for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). There was no adverse events reported.
8hr p/vax pt devel fine pinpoint rash on torso (front & back), itching;no fever or ill feeling;rash present for 3-4 days;did not seek medical attention;used ice packs day 1;
13 days after being given ROTATEQ, patient had intussusception requiring reduction in ER.
Pain in shoulder? injection site; numbness and swollen from injection site up through neck and face, only on left side. Very swollen and numb tongue and pain in left ear. When outside of car (we were on road trip driving all night) I would hear a warf/woofing sound? like the normal sounds were interrrupted. (I had this on and off for several weeks after the first vaccine, along with vertigo, which I also reported).   These symptoms were frightening as my throat also swelled up on left side this time  and I worried I wouldn?t be able to breathe. I felt like I had been to the dentist and given major shots of novicane. The next day it was better and by the third day almost gone. I was fine the first week after that but second week I have a heaviness in my legs and a different sense of gravity: I feel like it takes effort to walk. I have taken five Covid tests and have no symtoms other than lethargy and heavy-feel since then. Oh my hips hurt but I stumbled on uneven pavement the second week and fell down and that couldn?t be why
This case was reported by a consumer via call center representative and described the occurrence of fever in a 59-year-old female patient who received FLULAVAL QUADRIVALENT for prophylaxis. On 26th September 2018, the patient received the 1st dose of FLULAVAL QUADRIVALENT .5 ml. On 27th September 2018, 1 days after receiving FLULAVAL QUADRIVALENT, the patient experienced fever, dehydration, lightheadedness, muscle pain, nausea, vomiting, diarrhea and fatigue. On an unknown date, the outcome of the fever, dehydration, lightheadedness, muscle pain, nausea, vomiting, diarrhea and fatigue were not recovered/not resolved. It was unknown if the reporter considered the fever, dehydration, lightheadedness, muscle pain, nausea, vomiting, diarrhea and fatigue to be related to FLULAVAL QUADRIVALENT. Additional details were reported as follows: The husband of the patient reported that his wife contacted her physician, but has not been seen by her physician. Upon an internal review the listedness was manually corrected on 4th October 2018.
Cerebrovascular accident occurred approximately 2 days after administration. Patient also used cocaine during this time frame. Developed left side weakness and paresthesias. Received thrombolytics with improvement in symptoms. CVA proven on MRI.
Shortness of breath and difficulties breathing in the afternoon same day she received the vaccine. Mother called 911, and EMS provided an "injection" then monitored her at home for 1 hour. EMS left without taking patient to an ED.
Redness, warmth and edema @ injection site; scattered vesicular rash to both upper extremities, face and anterior chest.
patient is 16 years old. Johnson and Johnson COVID vaccine  approved for people over 18 years of age
Patient was given adjuvant solution only.  Pharmacist was distracted during mixing and accidentally gave the adjuvant before mixing with the lyophylized powder.  Pt will be re-vaccinated with properly mixed product on 7/13/21 per directions from GSK. No signs or symptoms reported.
The symptoms started on 1/15/2022. On 1/17/2022, I got a positive COVID-19 tests. On 1/21/2022, I did a telehealth visit and you prescribed antibiotics, steroids, inhaler, and cough suppressant. My symptoms were severe cough, loss of voice, left sided headache, fatigue, tiredness, dizziness, chest soreness, shortness of breath on exertion. My diagnosis was COVID-19 with croup.
Information has been received from a consumer concerning her son with no known allergies and no prior medical history who in 1997 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  There was no concomitant medication.  Subsequently, on an unspecified date, the patient showed an immunity to the mumps and to rubella but not to the measles.  Subsequently, the patient was revaccinated.  The patient sought unspecified medical attention.  Additional information has been requested.
Erythema at injection site; L>R. Slowly involved distal leg to feet, bilat, which became erythematous, warm to touch, no urticaria. Child fussy. Received 6.25mg Benadryl. Post 20-30 min observation legs/ feet no longer erythematous. He was no longer fussy.
pt recvd vax & devel headache, neuralgia of right arm & leg; visual difficulties & muscle weakness;
Pt noted soreness at approx 7 PM on 2-9-10 in R upper arm. Morning of 2-11-10 R arm was increasingly sore to the point that pt did not want to lift arm. Evening of 2-11-10 pt noticed redness and swelling forming a red band beginning above elbow reaching approx 5 1/2 inches up arm. Red area warm to touch. Pt took Ibuprofen 600 mg 2x daily x 2 days for relief of pain to R arm with relief. Pt has PCP will f/u if symptoms continue or get worse.
a. Fever (intermittent since 1/14/21; ranging from a little over 100 to 102.5 with no more than 24 hours between episodes) b. Chills (intermittent since 1/14/21) c. Fatigue (persistent since 1/14/21) d. Body ache (present from approx. 1/15/21 to 1/25/21) e. Headache (intermittent since 1/14/21) f. Mild cough (intermittent since 1/16/21)
Positive SARS-CoV-2 test; Congestion; Cough; Runny nose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive SARS-CoV-2 test), COUGH (Cough) and RHINORRHOEA (Runny nose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included CLOPIDOGREL and EZETIMIBE for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced COUGH (Cough) and RHINORRHOEA (Runny nose). On 16-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Positive SARS-CoV-2 test). On 16-Feb-2021, SARS-COV-2 TEST POSITIVE (Positive SARS-CoV-2 test) had resolved. At the time of the report, COUGH (Cough) and RHINORRHOEA (Runny nose) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 24-Feb-2021: upon internal review on 27-Sep-2022 case level seriousness was updated; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the mRNA-1273 does not contain a virus capable of causing infection, the occurrence of SARS-CoV-2 test positive  after vaccination is accessed as unlikely related to mRNA-1273.
Patient had not eaten breakfast or lunch, experienced sweating and dizziness. BP 101/58 HR 69 and 5 minutes later BP 102/55 HR73. Given water, apple juice, and crackers. Patient released in stable condition
varicella rash disseminated/gen;irritability;jerking/shaking no obvious sz activity;
Redness, swelling, warm and pain to L leg x 1d per mom. Seen 5/16/03. Admitted on 5/16/03 to hospital. Discharge 5/18/03. Seen f/u 5/21/03 on po antibiotics. The hospital discharge summary states pharyngitis, viral syndrome and URI.
Moderna Vaccine 1`st dose administered by Pediatrics 03/06/2021.  Arrived for second dose COVID-19 vaccine to clinic where only Pfizer 2nd doses were being administered. Recieved 2nd dose as Pfizer instead of Moderna on 4/5/2021
Case previously recorded as MA2009-3967. Initial case report received from a nurse, via Novartis Medical Communications, on 10 NOV 2009. A 3-year-old male patient was vaccinated with 0.25ml of S-OIV FLUVIRIN (batch no. 102042P1) i.m., on 05 NOV 09. On 06 NOV 2009, the patient developed a rash on the outer thigh near injection site. The patient was had been treated with BENADRYL and topical steroid. At the time of this report, the events were not recovered. MedCom reference no.: NA09-007916.
Numbness/right arm feels numb a little bit; Pins and needle sensation/Caller voiced that she is experiencing paresthesia/right arm feels like pins and needles/right arm is tingling like numbness; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 30 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 10Aug2021 14:30 (Lot number: FA6780, Expiration Date: 30Sep2021) at the age of 30 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "idiopathic allergy" (unspecified if ongoing), notes: A few years ago she was diagnosed with an idiopathic allergy; "anaphylaxis to something" (unspecified if ongoing), notes: Years ago she had anaphylaxis to something but she does not know what. There were no concomitant medications. The following information was reported: HYPOAESTHESIA (non-serious) with onset 10Aug2021, outcome "not recovered", described as "Numbness/right arm feels numb a little bit"; PARAESTHESIA (non-serious) with onset 10Aug2021, outcome "not recovered", described as "Pins and needle sensation/Caller voiced that she is experiencing paresthesia/right arm feels like pins and needles/right arm is tingling like numbness".  Additional information: There was no history of any previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines were administered on same date of the Pfizer suspect. The facility where the most recent COVID-19 vaccine was administered was Grocery Store. The vaccine was not administered at Military Facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient got her first vaccine that day around 14:30 pm and after receiving COVID-19 vaccine her right arm felt like pins and needles and numb a little bit. She was asking if that was normal. Tingling like numbness. This was the same arm she was vaccinated in. In regards to her arm, she stated she thinks she was fine. The patient wanted to know if there had been any reports of paresthesia after taking the Pfizer COVID-19 vaccine. The adverse events did not require a visit to Emergency room or Physician office. No relevant tests were done.  No follow-up attempts are possible. No further information is expected.
Hives noted the following morning that were described as red, hot and itchy.  Located on chest, head, hands and arms, side of right hip. Used Claritin and ice packs with some relief.   Also experienced numbness on her left shoulder and left chest to navel which subsided by mid day.   No breathing issues or any additional signs or symptoms.
Redness, swelling of upper R arm consistent with cellulitis. Started on Keflex.